-dutide
Peptides that activate both GLP-1 and glucagon receptors.
- Drugs ending in -dutide: 6
- Approved somewhere: 0
- With a US drug page: 0
- Stem
- -dutide
- Class
- Peptides that activate both GLP-1 and glucagon receptors
- Sub-stem of
- -tide: Peptides
Approved and clinical-stage drugs in ChEMBL whose names ending in -dutide, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Mazdutide | Phase 3 | — | — |
| Cotadutide | Phase 2 | GCGR, GLP1R | Glucagon receptor agonist |
| Efinopegdutide | Phase 2 | GLP1R, GCGR | Glucagon-like peptide 1 receptor agonist |
| Pegapamodutide | Phase 2 | GLP1R | Glucagon-like peptide 1 receptor agonist |
| Pemvidutide | Phase 2 | — | — |
| Survodutide | Phase 1 | GLP1R, GCGR | Glucagon-like peptide 1 receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO